Clinical Trial Protocol for Porcine Islet Xenotransplantation in South Korea

Background Islet transplantation holds promise for treating selected type 1 diabetes mellitus patients, yet the scarcity of human donor organs impedes widespread adoption. Porcine islets, deemed a viable alternative, recently demonstrated successful longterm survival without zoonotic risks in a clin...

Full description

Saved in:
Bibliographic Details
Main Authors: Byung-Joon Kim, Jun-Seop Shin, Byoung-Hoon Min, Jong-Min Kim, Chung-Gyu Park, Hee-Jung Kang, Eung Soo Hwang, Won-Woo Lee, Jung-Sik Kim, Hyun Je Kim, Iov Kwon, Jae Sung Kim, Geun Soo Kim, Joonho Moon, Du Yeon Shin, Bumrae Cho, Heung-Mo Yang, Sung Joo Kim, Kwang-Won Kim
Format: Article
Language:English
Published: Korean Diabetes Association 2024-11-01
Series:Diabetes & Metabolism Journal
Subjects:
Online Access:http://e-dmj.org/upload/pdf/dmj-2023-0260.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850220749197934592
author Byung-Joon Kim
Jun-Seop Shin
Byoung-Hoon Min
Jong-Min Kim
Chung-Gyu Park
Hee-Jung Kang
Eung Soo Hwang
Won-Woo Lee
Jung-Sik Kim
Hyun Je Kim
Iov Kwon
Jae Sung Kim
Geun Soo Kim
Joonho Moon
Du Yeon Shin
Bumrae Cho
Heung-Mo Yang
Sung Joo Kim
Kwang-Won Kim
author_facet Byung-Joon Kim
Jun-Seop Shin
Byoung-Hoon Min
Jong-Min Kim
Chung-Gyu Park
Hee-Jung Kang
Eung Soo Hwang
Won-Woo Lee
Jung-Sik Kim
Hyun Je Kim
Iov Kwon
Jae Sung Kim
Geun Soo Kim
Joonho Moon
Du Yeon Shin
Bumrae Cho
Heung-Mo Yang
Sung Joo Kim
Kwang-Won Kim
author_sort Byung-Joon Kim
collection DOAJ
description Background Islet transplantation holds promise for treating selected type 1 diabetes mellitus patients, yet the scarcity of human donor organs impedes widespread adoption. Porcine islets, deemed a viable alternative, recently demonstrated successful longterm survival without zoonotic risks in a clinically relevant pig-to-non-human primate islet transplantation model. This success prompted the development of a clinical trial protocol for porcine islet xenotransplantation in humans. Methods A single-center, open-label clinical trial initiated by the sponsor will assess the safety and efficacy of porcine islet transplantation for diabetes patients at Gachon Hospital. The protocol received approval from the Gachon Hospital Institutional Review Board (IRB) and the Korean Ministry of Food and Drug Safety (MFDS) under the Investigational New Drug (IND) process. Two diabetic patients, experiencing inadequate glycemic control despite intensive insulin treatment and frequent hypoglycemic unawareness, will be enrolled. Participants and their family members will engage in deliberation before xenotransplantation during the screening period. Each patient will receive islets isolated from designated pathogen-free pigs. Immunosuppressants and systemic infection prophylaxis will follow the program schedule. The primary endpoint is to confirm the safety of porcine islets in patients, and the secondary endpoint is to assess whether porcine islets can reduce insulin dose and the frequency of hypoglycemic unawareness. Conclusion A clinical trial protocol adhering to global consensus guidelines for porcine islet xenotransplantation is presented, facilitating streamlined implementation of comparable human trials worldwide.
format Article
id doaj-art-49fbc8ac31a44224b6c25d5a1279dced
institution OA Journals
issn 2233-6079
2233-6087
language English
publishDate 2024-11-01
publisher Korean Diabetes Association
record_format Article
series Diabetes & Metabolism Journal
spelling doaj-art-49fbc8ac31a44224b6c25d5a1279dced2025-08-20T02:06:57ZengKorean Diabetes AssociationDiabetes & Metabolism Journal2233-60792233-60872024-11-014861160116810.4093/dmj.2023.02602849Clinical Trial Protocol for Porcine Islet Xenotransplantation in South KoreaByung-Joon Kim0Jun-Seop Shin1Byoung-Hoon Min2Jong-Min Kim3Chung-Gyu Park4Hee-Jung Kang5Eung Soo Hwang6Won-Woo Lee7Jung-Sik Kim8Hyun Je Kim9Iov Kwon10Jae Sung Kim11Geun Soo Kim12Joonho Moon13Du Yeon Shin14Bumrae Cho15Heung-Mo Yang16Sung Joo Kim17Kwang-Won Kim18 Department of Internal Medicine, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Korea Tascom, Co. Ltd., Anyang, Korea Tascom, Co. Ltd., Anyang, Korea Department of Animal Health, Cheongju University College of Health and Medical Sciences, Cheongju, Korea Transplantation Research Institute, Seoul National University College of Medicine, Seoul, Korea Department of Laboratory Medicine, College of Medicine, Hallym University, Anyang, Korea Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul, Korea Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul, Korea Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul, Korea Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul, Korea Department of Medical Education, Ewha Womans University College of Medicine, Seoul, Korea GenNBio Inc., Seongnam, Korea GenNBio Inc., Seongnam, Korea GenNBio Inc., Seongnam, Korea GenNBio Inc., Seongnam, Korea GenNBio Inc., Seongnam, Korea GenNBio Inc., Seongnam, Korea GenNBio Inc., Seongnam, Korea Department of Internal Medicine, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, KoreaBackground Islet transplantation holds promise for treating selected type 1 diabetes mellitus patients, yet the scarcity of human donor organs impedes widespread adoption. Porcine islets, deemed a viable alternative, recently demonstrated successful longterm survival without zoonotic risks in a clinically relevant pig-to-non-human primate islet transplantation model. This success prompted the development of a clinical trial protocol for porcine islet xenotransplantation in humans. Methods A single-center, open-label clinical trial initiated by the sponsor will assess the safety and efficacy of porcine islet transplantation for diabetes patients at Gachon Hospital. The protocol received approval from the Gachon Hospital Institutional Review Board (IRB) and the Korean Ministry of Food and Drug Safety (MFDS) under the Investigational New Drug (IND) process. Two diabetic patients, experiencing inadequate glycemic control despite intensive insulin treatment and frequent hypoglycemic unawareness, will be enrolled. Participants and their family members will engage in deliberation before xenotransplantation during the screening period. Each patient will receive islets isolated from designated pathogen-free pigs. Immunosuppressants and systemic infection prophylaxis will follow the program schedule. The primary endpoint is to confirm the safety of porcine islets in patients, and the secondary endpoint is to assess whether porcine islets can reduce insulin dose and the frequency of hypoglycemic unawareness. Conclusion A clinical trial protocol adhering to global consensus guidelines for porcine islet xenotransplantation is presented, facilitating streamlined implementation of comparable human trials worldwide.http://e-dmj.org/upload/pdf/dmj-2023-0260.pdfclinical trialdiabetes mellitusislets of langerhansswinetransplantation
spellingShingle Byung-Joon Kim
Jun-Seop Shin
Byoung-Hoon Min
Jong-Min Kim
Chung-Gyu Park
Hee-Jung Kang
Eung Soo Hwang
Won-Woo Lee
Jung-Sik Kim
Hyun Je Kim
Iov Kwon
Jae Sung Kim
Geun Soo Kim
Joonho Moon
Du Yeon Shin
Bumrae Cho
Heung-Mo Yang
Sung Joo Kim
Kwang-Won Kim
Clinical Trial Protocol for Porcine Islet Xenotransplantation in South Korea
Diabetes & Metabolism Journal
clinical trial
diabetes mellitus
islets of langerhans
swine
transplantation
title Clinical Trial Protocol for Porcine Islet Xenotransplantation in South Korea
title_full Clinical Trial Protocol for Porcine Islet Xenotransplantation in South Korea
title_fullStr Clinical Trial Protocol for Porcine Islet Xenotransplantation in South Korea
title_full_unstemmed Clinical Trial Protocol for Porcine Islet Xenotransplantation in South Korea
title_short Clinical Trial Protocol for Porcine Islet Xenotransplantation in South Korea
title_sort clinical trial protocol for porcine islet xenotransplantation in south korea
topic clinical trial
diabetes mellitus
islets of langerhans
swine
transplantation
url http://e-dmj.org/upload/pdf/dmj-2023-0260.pdf
work_keys_str_mv AT byungjoonkim clinicaltrialprotocolforporcineisletxenotransplantationinsouthkorea
AT junseopshin clinicaltrialprotocolforporcineisletxenotransplantationinsouthkorea
AT byounghoonmin clinicaltrialprotocolforporcineisletxenotransplantationinsouthkorea
AT jongminkim clinicaltrialprotocolforporcineisletxenotransplantationinsouthkorea
AT chunggyupark clinicaltrialprotocolforporcineisletxenotransplantationinsouthkorea
AT heejungkang clinicaltrialprotocolforporcineisletxenotransplantationinsouthkorea
AT eungsoohwang clinicaltrialprotocolforporcineisletxenotransplantationinsouthkorea
AT wonwoolee clinicaltrialprotocolforporcineisletxenotransplantationinsouthkorea
AT jungsikkim clinicaltrialprotocolforporcineisletxenotransplantationinsouthkorea
AT hyunjekim clinicaltrialprotocolforporcineisletxenotransplantationinsouthkorea
AT iovkwon clinicaltrialprotocolforporcineisletxenotransplantationinsouthkorea
AT jaesungkim clinicaltrialprotocolforporcineisletxenotransplantationinsouthkorea
AT geunsookim clinicaltrialprotocolforporcineisletxenotransplantationinsouthkorea
AT joonhomoon clinicaltrialprotocolforporcineisletxenotransplantationinsouthkorea
AT duyeonshin clinicaltrialprotocolforporcineisletxenotransplantationinsouthkorea
AT bumraecho clinicaltrialprotocolforporcineisletxenotransplantationinsouthkorea
AT heungmoyang clinicaltrialprotocolforporcineisletxenotransplantationinsouthkorea
AT sungjookim clinicaltrialprotocolforporcineisletxenotransplantationinsouthkorea
AT kwangwonkim clinicaltrialprotocolforporcineisletxenotransplantationinsouthkorea